14156-91-3 Usage
Description
3-(3-METHYL-PIPERIDIN-1-YL)-PROPYLAMINE, also known as MPPA, is a piperidine derivative with a molecular formula of C10H22N2. It is a clear, colorless liquid that is highly soluble in water and organic solvents. MPPA is commonly used as a pharmaceutical intermediate in the synthesis of organic materials and is known for its versatile applications and unique properties in the chemical industry.
Uses
Used in Pharmaceutical Industry:
3-(3-METHYL-PIPERIDIN-1-YL)-PROPYLAMINE is used as a pharmaceutical intermediate for the synthesis of various organic materials. Its unique properties and reactivity make it a valuable component in the development of new drugs and pharmaceutical products.
Used in Agrochemical Industry:
3-(3-METHYL-PIPERIDIN-1-YL)-PROPYLAMINE is used in the manufacture of agrochemicals, where it serves as a key component in the development of pesticides, herbicides, and other agricultural chemicals. Its versatility and solubility in water and organic solvents contribute to its effectiveness in these applications.
Used in Specialty Chemicals Industry:
3-(3-METHYL-PIPERIDIN-1-YL)-PROPYLAMINE is utilized in the production of specialty chemicals, where it is employed as a building block for the synthesis of various chemical compounds. Its unique properties and reactivity make it an essential component in the creation of high-performance materials for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 14156-91-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,1,5 and 6 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 14156-91:
(7*1)+(6*4)+(5*1)+(4*5)+(3*6)+(2*9)+(1*1)=93
93 % 10 = 3
So 14156-91-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H20N2/c1-9-4-2-6-11(8-9)7-3-5-10/h9H,2-8,10H2,1H3/p+2/t9-/m1/s1
14156-91-3Relevant articles and documents
INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2
-
Page 45; 46, (2008/06/13)
Pharmaceutical compositions containing organic compounds or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.